$FSBW Cashflow Statement | Understand Stock

$FSBW

$43.70 -$0.07 (0.16%) Close

$FSBW Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income
Adjustments to reconcile net income to net cash from operating activities
Provision for credit losses
Depreciation, amortization and accretion
Compensation expense related to stock options and restricted stock awards
ESOP compensation expense for allocated shares
Benefit for deferred income taxes
Earnings on cash surrender value of BOLI
Gain on sale of loans held for sale
Gain on sale of portfolio loans
Gain on sale of MSRs
Loss on sale of investment securities, net
Change in fair value on portfolio loans measured under the fair value option
Origination of loans held for sale
Proceeds from sale of loans held for sale
Gain on purchase of tax credits
Loss on disposal of fixed assets
Purchase of tax credits
Impairment (recovery) of MSRs
Gain on sale of OREO
Changes in operating assets and liabilities
Accrued interest receivable
Other assets
Other liabilities
Net cash from operating activities
CASH FLOWS (USED BY) FROM INVESTING ACTIVITIES
Proceeds from sale of investment securities
Maturities, prepayments, and calls
Purchases
Maturities of certificates of deposit at other financial institutions
Purchase of certificates of deposit at other financial institutions
Portfolio loan originations and principal collections, net
Net cash from acquisitions
Proceeds from sale of MSRs
Proceeds from sale of portfolio loans
Purchase of portfolio loans
Proceeds from sale of OREO, net
Purchase of premises and equipment
Proceeds from bank owned life insurance death benefits
Change in FHLB stock, net
Net cash (used by) from investing activities
CASH FLOWS FROM (USED BY) FINANCING ACTIVITIES
Net increase in deposits
Net increase (decrease) in deposits
Proceeds from borrowings
Repayments of borrowings
Dividends paid on common stock
Net proceeds from issuance of subordinated notes
Repayment of subordinated notes
Disbursements from stock options exercised, net
Common stock repurchased for employee/director taxes paid on restricted stock awards
Issuance of common stock - employee stock purchase plan
Common stock repurchased
Net cash from (used by) financing activities

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of year
CASH AND CASH EQUIVALENTS, end of year
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of year
CASH AND CASH EQUIVALENTS, end of year
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION
Interest on deposits and borrowings
Income taxes
SUPPLEMENTARY DISCLOSURES OF NONCASH OPERATING, INVESTING AND FINANCING ACTIVITIES
Change in fair value on available-for-sale investment securities
Change in fair value on fair value and cash flow hedges
Change in fair value on portfolio loans measured under the fair value option
Retention in gross MSRs from loan sales
OREO received in settlement of loans
Transfer of closed retail branch to OREO
ROU assets in exchange for lease liabilities
Acquisitions:
Assets acquired
Liabilities assumed

Comments